Boehringer Ingelheim has reported encouraging Phase II trial results for apecotrep (BI 764198), a potential first-in-class oral TRPC6 inhibitor being developed for primary focal segmental ...
XDA Developers on MSN
How I built a lightweight second brain using just Raindrop.io
With a few simple tweaks, Raindrop.io became my favorite low-friction second brain ...
Hosted on MSN
How to Create Spooky Bookmark
Discover a creative way to get ready for Halloween with this guide to making a spooky bookmark. The video walks viewers through simple art techniques to craft a fun and festive accessory inspired by ...
Boehringer Ingelheim has been awarded the Global Top Employer 2026 certification by the Top Employers Institute for the sixth consecutive year, reinforcing its long-standing commitment to employee ...
Meta said it has secured agreements with energy companies Vistra, TerraPower and Oklo, which are working on nuclear power technologies. They're planning to work together to eventually power Meta's ...
European power and natural gas markets are set to undergo a major overhaul amid plans to extend trading hours and align them with other global commodities. The move comes after traders and hedge funds ...
The German activist network Volcano Group claimed responsibility for an arson attack that cut power to about 50,000 households and 2,000 businesses in southwest Berlin on Saturday. The far-left ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results